Know Cancer

or
forgot password


N/A
18 Years
N/A
Open (Enrolling)
Both
Carcinoma, Non-Small-Cell Lung

Thank you

Trial Information


Inclusion Criteria:



- Non-small cell lung cancer

- Available plasma and pathologically confirmed tissue slices(pre-chemo and pre-radio
therapy)

- Informed Consent

Exclusion Criteria:

- N/A

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Outcome Measure:

To determine the consistence of EGFR mutation status in paired tissue and plasma samples

Outcome Time Frame:

3 months

Safety Issue:

No

Principal Investigator

Mengzhao Wang, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Peking Union Medical College Hospital

Authority:

China: Ministry of Health

Study ID:

LCC001

NCT ID:

NCT01382992

Start Date:

June 2010

Completion Date:

Related Keywords:

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Non-Small-Cell Lung
  • erbB-1
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung

Name

Location